News|Articles|December 5, 2023

Infection Intel: BiomX, SHEA, CSL and Arcturus Therapeutics

Staying Ahead with Company Updates and Product Innovations. This article's news is from BiomX, SHEA, and CSL and Arcturus Therapeutics.

Infection Intel is the column for Infection Control Today^® (ICT^®) that covers the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.

Newsletter

Stay prepared and protected with the Infection Control Today newsletter, delivering essential updates, best practices, and expert insights for infection prevention professionals.

Subscribe

Related Content

Microscopic view of Cyclospora cayetanensis oocysts under magnification, stained bright red. cyclosporiasis outbreak, foodborne parasites, intestinal infections. water pollution. (Adobe Stock 2122448953 by alones)

Latest CME

Video

A Shield of Protection: Unmet Needs in COVID-19 Prevention and Control

Onyema Ogbuagu, MD, FACP, FIDSA; Jeffery A. Goad, PharmD, MPH; William P. Hanage, PhD

Multimedia

Empowering HIV Management: Evidence-Based Prevention and Treatment Strategies

Onyema Ogbuagu, MD, FACP, FIDSA

Infection Intel: BiomX, SHEA, CSL and Arcturus Therapeutics

Related Content

Roche Expands Cyclospora PCR Testing Portfolio to Support Ongoing US Outbreak Response

Lead Apron Safety Requires Collaboration Across Infection Prevention, OR, and Radiology Teams

How Claryx Uses Genomics to Help Infection Prevention Teams Find Outbreaks Faster

Next-Generation Mpox Vaccine Shows Promise for Durable Protection and Future Outbreak Preparedness

Burnout to Balance: How Mentorship Helped One Infection Preventionist Reclaim Her Purpose